Inmune Bio INMB Insider Ownership

NASDAQ INMB
$2.46 -0.05 (-1.99%)
At close: Sep 9, 2026 · 4:00 PM EDT

Insider Holdings by Owner

3.26Mn Shares

Insider Ownership Statistics

as of 30 Sep, 2026
Insider Ownership
17.40%
-6.96% pp QoQ
Shares Held by Insiders
4.62Mn
filed for Sep 2026
-28.57% QoQ
Shares Outstanding
26.59Mn
26,585,258 shares
Direct Holdings
4.47Mn
Indirect: 153.79K
Net Shares Traded (QoQ)
-1.85Mn
net selling in Sep 2026
Insiders Holding Shares
5
with Form 4 holdings on file

Shares Owned by Insiders

Shares held % of outstanding
Latest
Average ownership
Peak ownership

Shares Purchased/Sold by Insiders

Bought Sold
Latest quarter
Net over range
Buying quarters

Insider Ownership Summary

Quarter ending 30 Sep, 2026

As of September 09, 2026, the three largest insider holders of INMB are Raymond Joseph Tesi (President And Ceo, 1.55Mn shares), Raymond Joseph Tesi (President And Ceo, 1.55Mn shares), Mark William Lowdell (Chief Scientific Officer, 1.52Mn shares).

Form 4 Holdings

Insiders Holding INMB

Insiders 5
Shares held 3.26Mn
Of outstanding 12.26%
# Insider Position Direct Indirect Total Share of Insiders Last Filed
1 Raymond Joseph Tesi President And Ceo 1,554,106 0 1,554,106 47.7% 16 Sep, 2024
2 Mark William Lowdell Chief Scientific Officer 1,518,017 0 1,518,017 46.6% 07 Jul, 2026
3 Scott Juda Director 86,404 0 86,404 2.7% 07 Jul, 2026
4 Timothy J Schroeder Director 0 82,187 82,187 2.5% 14 Jul, 2023
5 James Kelly Ganjei Director 17,793 0 17,793 0.5% 23 Mar, 2022

Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.

Form 4 Filings

401 Insider Transactions

Source SEC Form 4
Latest quarter Sep 2026
Download Data
Date Insider Position Transaction Shares Price Value Shares Held After Ownership
02 Jul, 2026 Mark William Lowdell Chief Scientific Officer Acquired M 7,211 $1.40 $10.10K 1,518,017 Direct
02 Jul, 2026 Scott Juda Director Acquired M 14,801 $1.40 $20.72K 86,404 Direct
02 Jul, 2026 Mark William Lowdell Chief Scientific Officer Disposed X 7,211 $0.13 $901 7,212 Direct
02 Jul, 2026 Scott Juda Director Disposed X 14,801 $0.13 $1.85K 14,802 Direct
01 Dec, 2025 Timothy J Schroeder Director Acquired A 150,000 $0.00 $0 150,000 Direct
01 Dec, 2025 James Kelly Ganjei Director Acquired A 150,000 $0.00 $0 150,000 Direct
01 Dec, 2025 Timothy J Schroeder Director Acquired A 150,000 $0.00 $0 150,000 Direct
01 Dec, 2025 Mark William Lowdell Chief Scientific Officer Acquired A 600,000 $0.00 $0 600,000 Direct
01 Dec, 2025 Scott Juda Director Acquired A 150,000 $0.00 $0 150,000 Direct
01 Dec, 2025 Timothy J Schroeder Director Acquired A 150,000 $0.00 $0 150,000 Direct
01 Dec, 2025 Timothy J Schroeder Director Acquired A 150,000 $0.00 $0 150,000 Direct
01 Dec, 2025 Cory Randall Ellspermann Cfo Acquired A 300,000 $0.00 $0 300,000 Direct
01 Dec, 2025 Marcia Allen Director Acquired A 150,000 $0.00 $0 150,000 Direct
18 Nov, 2025 Mark William Lowdell Chief Scientific Officer Disposed D 400,000 0 Direct
18 Nov, 2025 Timothy J Schroeder Director Disposed D 108,000 0 Direct
18 Nov, 2025 Marcia Allen Director Disposed D 108,000 0 Direct
18 Nov, 2025 Timothy J Schroeder Director Disposed D 108,000 0 Direct
18 Nov, 2025 Timothy J Schroeder Director Disposed D 108,000 0 Direct
18 Nov, 2025 Timothy J Schroeder Director Disposed D 108,000 0 Direct
18 Nov, 2025 James Kelly Ganjei Director Disposed D 108,000 0 Direct